Connor, Clark & Lunn Investment Management (CC&L)
CLSD

Connor, Clark & Lunn Investment Management (CC&L)’s Clearside Biomedical CLSD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CLSD Stock Details CLSD Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
2024
Q1 		$38.9K Buy
2023
Q3 		– Sell
2023
Q2 		$17.4K Sell
2023
Q1 		$55.9K Sell
2022
Q4 		$63.9K Sell
2022
Q3 		$76K Buy
2022
Q2 		$74K Sell
2022
Q1 		$181K Buy